Sign in

CIK 0001326205

  • Non-accelerated filer
  • Smaller reporting company

IGC Pharma, Inc.

Sign in to watch
Ticker
IGC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MD
Entity type
Operating
EIN
202760393
Phone
+1 301-529-4996
Business address
10224 FALLS ROAD, POTOMAC, MD, 20854
Former names
India Globalization Capital, Inc.
  1. 4 Conversion 10% owner acquired 151,234 shares (conversion)
  2. 4 Open-market sale 10% owner sold 423,986 shares at $0.97 ($410,842)
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale 10% owner sold 1,113,025 shares at an average $1.18 ($1,317,072)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Exec. Chairman & CEO acquired 34,410 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Conversion 10% owner acquired 107,024 shares (conversion)
  9. 4 Open-market buy 10% owner bought 200,000 shares
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale 10% owner sold 1,850 shares at an average $4.85 ($8,980)
  12. 4 Open-market sale 10% owner sold 17,832 shares at an average $4.94 ($83,195)
  13. 4 Open-market buy 10% owner bought 26,860 shares at an average $5.14 ($133,004)
  14. 4 Open-market buy 10% owner bought 25,685 shares at an average $5.43 ($138,355)
  15. 4 Open-market sale 10% owner sold 42,746 shares at an average $5.47 ($232,637)
  16. 4 Open-market buy 10% owner bought 34,005 shares at an average $5.21 ($177,026)
  17. 4 Open-market sale 10% owner sold 58,695 shares at an average $5.00 ($293,522)
  18. 4 Open-market sale 10% owner sold 24,699 shares at an average $4.69 ($115,797)
  19. 4 Open-market buy 10% owner bought 29,608 shares at an average $4.82 ($128,252)
  20. 4 Open-market buy 10% owner bought 14,465 shares at an average $4.38 ($63,310)

Page 7 of 8 · 156 filings